Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.0042 | 1 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |